Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;16(1):114-121.
doi: 10.1007/s10388-018-0646-4. Epub 2018 Oct 15.

Appropriateness of the institute certification system for esophageal surgeries by the Japan Esophageal Society: evaluation of survival outcomes using data from the National Database of Hospital-Based Cancer Registries in Japan

Satoru Motoyama  1   2 , Eri Maeda  3 , Masahiko Yano  4 , Takushi Yasuda  4 , Masaichi Ohira  4 , Yuichiro Doki  4 , Yasushi Toh  4 , Takahiro Higashi  5 , Hisahiro Matsubara  4 ; Japan Esophageal Society
Affiliations

Appropriateness of the institute certification system for esophageal surgeries by the Japan Esophageal Society: evaluation of survival outcomes using data from the National Database of Hospital-Based Cancer Registries in Japan

Satoru Motoyama et al. Esophagus. 2019 Jan.

Abstract

Background: Since 2013, The Japan Esophageal Society has been certifying "Authorized Institute for Board Certified Esophageal Surgeon (AIBCES)" to contribute to improving national medical care by enhancing the professional knowledge and skills of esophageal surgeons. However, the appropriateness on this certification system has not yet been verified. Our aim was to assess the appropriateness of the institute certification system for esophageal surgeries used by the medical society.

Methods: Using data from the National Database of Hospital-based Cancer Registries, we analyzed the 5-year overall survival rates among 2135 patients with thoracic esophageal cancer who underwent an esophagectomy at 53 AIBCES or 141 non-AIBCES.

Results: There were 1343 (63%) patients who underwent surgery at an AIBCES and 792 (37%) who underwent surgery at a non-AIBCES. Registered patients were followed up for a median of 53 (range 1-88) months. Over the followed-up period examined, 670 (50%) patients treated at an AIBCES died and 455 (57%) treated at a non-AIBCES died. Comparison of the Kaplan-Meier survival curves indicated that patients with cStage II or cStage III disease treated at an AIBCES had significantly better 5-year survival rates than those treated at a non-AIBCES (55.4% vs. 44.9% and 38.0% vs. 30.3%, respectively). Univariate and multivariate analyses stratified based on stages and adjuvant therapies revealed that institute certification (AIBCES vs. non-AIBCES) is a significant independent factor for 5-year survival.

Conclusions: The institute certification system used by the Japan Esophageal Society may be appropriate, as indicated by improved 5-year survival outcomes. The institute certification system has the potential to contribute to a more appropriate medical delivery system in the future.

Keywords: Esophageal cancer; Esophagectomy; Institute certification; Survival outcome.

PubMed Disclaimer

Conflict of interest statement

There are no financial or other relations that could lead to a conflict of interest.

Figures

Fig. 1
Fig. 1
Kaplan–Meier curves for overall survival of patients with all stages thoracic esophageal cancer operated on at Authorized Institutes for Board-Certified Esophageal Surgeons (AIBCES) and non-AIBCES. There is a significant difference in 5-year overall survival
Fig. 2
Fig. 2
Kaplan–Meier curves for overall survival of patients with cStage I, II, III, or IV thoracic esophageal cancer operated on at Authorized Institutes for Board Certified Esophageal Surgeons (AIBCES) and non-AIBCES. There are significant differences in 5-year overall survival for cStage II and III
See this image and copyright information in PMC

References

    1. Tachimori Y, Ozawa S, Numasaki H, et al. Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Comprehensive Registry of Esophageal Cancer in Japan, 2010. Esophagus. 2017;14:189–214. doi: 10.1007/s10388-017-0578-4. - DOI - PMC - PubMed
    1. Chen MF, Yang YH, Lai CH, et al. Outcome of patients with esophageal cancer: a nationwide analysis. Ann Surg Oncol. 2013;20:3023–3030. doi: 10.1245/s10434-013-2935-4. - DOI - PubMed
    1. Tachimori Y, Ozawa S, Numasaki H, et al. Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus. 2016;13:1–7. doi: 10.1007/s10388-015-0515-3. - DOI - PMC - PubMed
    1. Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907) Ann Surg Oncol. 2012;19:68–74. doi: 10.1245/s10434-011-2049-9. - DOI - PubMed
    1. van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–2084. doi: 10.1056/NEJMoa1112088. - DOI - PubMed

MeSH terms

LinkOut - more resources